Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic; Neuritis, With Demyelination”

8 trials

Showing 8 of 8 results

Testing effectiveness (Phase 2)Ended earlyNCT03536559
What this trial is testing

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisOptic NeuropathyOptic; Neuritis, With Demyelination
Clene Nanomedicine 73
Post-approval studies (Phase 4)WithdrawnNCT00037115
What this trial is testing

Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.

Who this might be right for
Demyelinating DisordersMultiple SclerosisOptic Neuritis+2 more
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Early research (Phase 1)Study completedNCT03630497
What this trial is testing

BN201 SAD MAD Study in Healthy Subjects

Who this might be right for
Optic NeuritisOptic; Neuritis, With Demyelination
Accure Therapeutics 48
Large-scale testing (Phase 3)Study completedNCT02200770
What this trial is testing

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
MedImmune LLC 231
Large-scale testing (Phase 3)Study completedNCT04626921
What this trial is testing

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Clene Nanomedicine 55
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Large-scale testing (Phase 3)Study completedNCT01524250
What this trial is testing

Optic Neuritis Recovery After Oral or IV Corticosteroids

Who this might be right for
Optic Neuritis
London Health Sciences Centre 51
Testing effectiveness (Phase 2)UnknownNCT01879527
What this trial is testing

Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve

Who this might be right for
Optic; Neuritis, With Demyelination
Medical University of Vienna 78

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation